Study registration: *
Publication Singh C, Epidemiol Infect, 2021
Dates: 2021-04-01 to 2021-06-30
Funding: No specific funding (This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.)
Conflict of interest: no COI (Conflict of interest: None.)
Methods | |
Study design:Case-control Description of participants: Adults aged 45 and up in a single centre in India Inclusion criteria:
Exclusion criteria:
Follow-up duration (months): 3.00 | |
Vaccines: |
|
Variant description : |
|
Variant name: Delta Evidence: Indirect evidence (prevalence of variant in the population: 30 to 99%) | |
Documents available |
Protocol NR Statistical plan No Data-sharing stated:
Unclear |
General comment |
In addition to the published report, the supplementary material were used in data extraction and risk of bias assessment. Follow-up time was estimated using the date of start of vaccination for the elderly and individuals aged above 45 years with comorbidities (March 1, 2021); however, for healthcare workers (6% of the study sample) and front-line workers it was earlier (January 16, 2021). The main concerns were uncontrolled confounding, adjustment for a variable potentially on the causal pathway, selection bias and potential differential misclassification of vaccination status. |